Clinical Trial Update: Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PF-04965842 in adolescents and adults with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-04965842

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2020-04-21